Lv1
30 积分 2024-01-29 加入
Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial
6天前
已完结
Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report
6天前
已完结
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial
24天前
已完结
Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
1个月前
已完结
Structure and function of the blood–brain barrier
1个月前
已完结
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
1个月前
已完结
Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
1个月前
已完结
[Cancer incidence and mortality across diverse geographical regions in China, 2024]
1个月前
已完结
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial
2个月前
已完结
皖公网安备34019202002308
